The US government is ready to begin allocation of Regeneron's casirivimab-imdevimab monoclonal antibody combination, which just received an EUA for use as a COVID-19 treatment. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
